Loading Results

Seidman Cancer Center

Showing   of 53 results

Burata kidney scans

UH Seidman Cancer Center Offers Patients Rare Access to New Kidney Cancer Tracer

UH Seidman Cancer Center is one of just a few cancer centers nationwide to offer its patients early access to a novel and more sensitive method of diagnosing kidney cancer.

University Hospitals Researcher and Team Awarded $2.78M Federal Grant to Improve Rectal Cancer Treatment with Artificial Intelligence

Co- Principal investigator, Dr. Emily Steinhagen, from UH Seidman Cancer Center leads the team with colleagues from the radiology, pathology, oncology, biostatistics and surgery departments at CWRU, Cleveland Clinic, UH and Medical College Wisconsin.

Nathan Berger, MD

International Leader in Cancer Research at University Hospitals Seidman Cancer Center Passes Away

Nathan Berger, MD, Ph.D was Chief of the Hematology and Oncology Division of University Hospitals.

UH Seidman Cancer Center Researchers Awarded ASCO Young Investigator Awards

James Ignatz-Hoover, MD, PhD and Courtney Pisano, DO, MS, MPH will each receive $50,000 research funding from The American Society of Clinical Oncology for their respective research projects in clinical oncology.

UH First Health System in Northeast Ohio to Widely Offer Galleri®, a Multi-cancer Early Detection Blood Test Designed to Screen for More Than 50 Types of Cancer

UH planning multiple screening events with first responders throughout region – including the first with the city of Highland Heights.

University Hospitals Physician-scientist, Linda Cummings, Selected for American Gastroenterological Association Pilot Research Award

Research will address growing problem of antimicrobial resistance in eradicating Helicobacter Pylori (H. pylori), a bacterial infection that increases the risk of gastric cancer and peptic ulcer disease.

Getty illustration of 3d prostate cancer illustration

Novel Oral Hormone Therapy Shows Promising Results for Prostate Cancer Treatment with Radiation Therapy

A high impact study led by Daniel Spratt, MD, demonstrates the safety and efficacy of a novel oral hormone therapy, relugolix, in conjunction with radiation therapy for treating men with localized and advanced prostate cancer.

Laura Bukavina, MD, MPH Urology

Bladder Cancer Expert, Known for her Medical Missions in Ukraine, Returns to University Hospitals Urology Institute and UH Seidman Cancer Center

Cleveland urologist returns to UH Urology Institute and UH Seidman Cancer Center after completing prestigious fellowship in urologic oncology. October mission to Ukraine will include two fellow UH urologists.

Results are loading...